The in vivo dermal absorption and metabolism of [4-14C]coumarin by rats and by human volunteers under simulated conditions of use in fragrances

被引:39
作者
Ford, RA
Hawkins, DR
Mayo, BC
Api, AM
机构
[1] Res Inst Fragrance Mat Inc, Hackensack, NJ 07601 USA
[2] Huntingdon Life Sci Ltd, Huntingdon PE18 6ES, England
关键词
skin absorption; coumarin; rat; human;
D O I
10.1016/S0278-6915(00)00123-X
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The disposition and metabolic fate of [4-C-14]coumarin in a 70% aqueous ethanol solution was studied in male Lister Hooded rats after occluded dermal application and in three male volunteers after an exposure designed to simulate that which may be encountered when using an alcohol-based perfumed product. In both cases, the 6-h exposure was 0.02 mg/cm(2) (rats 0.023 mg/kg and humans 0.77 mg/kg). In both, coumarin was quickly absorbed, distributed and excreted in urine and feces, although fecal excretion of coumarin in humans was only 1% of the applied dose as opposed to 21% in rats. Total absorption was 72% of the applied dose with rats and 60% with humans. Peak plasma radioactivity in both was at 1 h. The mean plasma half-life of coumarin and metabolites was approximately 1.7 h for humans and 5 h for rats. In humans, coumarin was primarily metabolized to and excreted in urine as 7-hydroxycoumarin glucuronide and 7-hydroxycoumarin sulfate. Small amounts of unconjugated 7-hydroxycoumarin and o-hydroxyphenylacetic acid (o-HPAA) were also excreted. In rats, about twenty metabolites were present, but only o-HPAA was identified. These studies show the rat is a very poor model for humans and toxicity in the rat cannot be extrapolated to humans. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 32 条
[1]  
BAUER K, 1990, COMMON FRAGRANCE FLA, P122
[2]   Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse [J].
BeckleyKartey, SAJ ;
Hotchkiss, SAM ;
Capel, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 145 (01) :34-42
[3]   Selective Clara cell injury in mouse lung following acute administration of coumarin [J].
Born, SL ;
Fix, AS ;
Caudill, D ;
Lehman-McKeeman, LD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 151 (01) :45-56
[4]  
Born SL, 1997, DRUG METAB DISPOS, V25, P1318
[5]  
BORN SL, 1998, TOXICOL SCI, V42, P400
[6]   Effects of coumarin following perinatal and chronic exposure in Sprague-Dawley rats and CD-1 mice [J].
Carlton, BD ;
Aubrun, JC ;
Simon, GS .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1996, 30 (01) :145-151
[7]  
Clark G. C., 1995, Perfumer & Flavorist, V20, P23
[8]   CRITICAL-REVIEW OF THE TOXICOLOGY OF COUMARIN WITH SPECIAL REFERENCE TO INTERSPECIES DIFFERENCES IN METABOLISM AND HEPATOTOXIC RESPONSE AND THEIR SIGNIFICANCE TO MAN [J].
COHEN, AJ .
FOOD AND COSMETICS TOXICOLOGY, 1979, 17 (03) :277-289
[9]   PHASE-II STUDY OF COUMARIN AND CIMETIDINE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA [J].
DEXEUS, FH ;
LOGOTHETIS, CJ ;
SELLA, A ;
FITZ, K ;
AMATO, R ;
REUBEN, JM ;
DOZIER, N .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) :325-329
[10]   THE PHARMACOLOGY, METABOLISM, ANALYSIS, AND APPLICATIONS OF COUMARIN AND COUMARIN-RELATED COMPOUNDS [J].
EGAN, D ;
OKENNEDY, R ;
MORAN, E ;
COX, D ;
PROSSER, E ;
THORNES, RD .
DRUG METABOLISM REVIEWS, 1990, 22 (05) :503-529